CANSINO BIOLOGICS INC (CASBF)
Clinical trial NCT06708286 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-05-30 → 2026-03-30 3. primary completion date: 2025-05-30 → 2025-07-01
Clinical trial NCT06708286 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-05-30 → 2026-03-30 3. primary completion date: 2025-05-30 → 2025-07-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical